# [S,S]-Reboxetine Dose-Range Finding Trial

> **NCT00288652** · PHASE2 · COMPLETED · sponsor: **Pfizer** · enrollment: 280 (—)

## Conditions studied

- Pain

## Interventions

- **DRUG:** [S,S]-Reboxetine

## Key facts

- **NCT ID:** NCT00288652
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-03
- **Primary completion:** —
- **Final completion:** 2007-02
- **Target enrollment:** 280 (—)
- **Last updated:** 2011-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00288652

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00288652, "[S,S]-Reboxetine Dose-Range Finding Trial". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00288652. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*